Skip to content

A prospective study under endoscopic treatment which examines the convenient propofol use

A prospective study under endoscopic treatment which examines the convenient propofol use - A prospective study under endoscopic treatment which examines the convenient propofol use

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010547
Enrollment
50
Registered
2013-04-19
Start date
2013-04-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patient who owns the digestive diseases diagnosed as passing and the endoscopic treatment under vein general anesthesia being requirement

Interventions

Treatment will set in necessary 50 cases endoscopically by December 31, 2016 from the ethics committee approved the study. It is kept calm, increasing from the amount of 1 ml/h for 4 minutes of weight

Sponsors

Juntendo university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient who owns the digestive diseases diagnosed as passing and the endoscopic treatment under vein general anesthesia being requirement

Exclusion criteria

Exclusion criteria: 1) The example of Informed Consent (IC) refusal.2) The direction which has merged critical liver disease, cardiac disease, a respiratory ailment, etc., and is considered that operative endoscopy is difficult.3)patient who haveallergy to eggs.4)patient who have unknown or serious allergic constitution. 4)the patient whom the doctor specializing in an exam judged to be unfit as focus of our study

Design outcomes

Primary

MeasureTime frame
validity by propofol use by this medication method

Secondary

MeasureTime frame
evaluation of dose by the background factor difference of patient with the use of propofol

Countries

Japan

Contacts

Public Contactkenshi matsumoto

juntendo university gastroenterology

kmatumo@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026